Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm

BACKGROUND: AVAGAST was an international, randomized, placebo-controlled phase III study of chemotherapy with or without bevacizumab as first-line therapy for patients with advanced gastric cancer. We performed exploratory analyses to evaluate regional differences observed in the trial. METHODS: Ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawaki, Akira, Yamada, Yasuhide, Yamaguchi, Kensei, Nishina, Tomohiro, Doi, Toshihiko, Satoh, Taroh, Chin, Keisho, Boku, Narikazu, Omuro, Yasushi, Komatsu, Yoshito, Hamamoto, Yasuo, Koizumi, Wasaburo, Saji, Shigehira, Shah, Manish A., Van Cutsem, Eric, Kang, Yoon-Koo, Iwasaki, Junko, Kuriki, Hiroshi, Ohtsuka, Wataru, Ohtsu, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906488/
https://www.ncbi.nlm.nih.gov/pubmed/29058097
http://dx.doi.org/10.1007/s10120-017-0773-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906488/
https://www.ncbi.nlm.nih.gov/pubmed/29058097
http://dx.doi.org/10.1007/s10120-017-0773-y

Ejemplares similares